Complications of Oxygen Therapy in Veterinary Patients

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Oxygen toxicity arises from excessive reactive oxygen species (ROS) overwhelming endogenous antioxidant defenses, primarily damaging pulmonary endothelial and epithelial cells. Clinical signs include progressive dyspnea, cough, and worsening hypoxemia despite stable FiO₂, with radiographic findings mimicking ARDS. Management involves reducing FiO₂ to the lowest effective level (SpO₂ 92-97% or PaO₂ 80-100 mmHg) and limiting exposure above 0.60 to the shortest duration necessary.

• Absorption atelectasis occurs when high FiO₂ replaces alveolar nitrogen, leading to rapid gas absorption and alveolar collapse, particularly in compromised airways. This manifests as worsening oxygenation despite continued high FiO₂ and is diagnosed by a falling PaO₂/FiO₂ ratio and radiographic evidence of collapse. Prevention includes maintaining FiO₂ below 0.60 when possible and utilizing positive end-expiratory pressure (PEEP) in ventilated patients.

• Oxygen-induced hypoventilation is a concern in patients with chronic hypercapnia who rely on hypoxic drive. High FiO₂ can blunt this drive, leading to increased PaCO₂ and progressive lethargy. Monitoring end-tidal CO₂ (ETCO₂) or PaCO₂ is crucial in at-risk patients (e.g., severe brachycephalic syndrome), with titration of FiO₂ to target SpO₂ and consideration of ventilatory support if hypercapnia persists.

• Mucosal drying and airway irritation are common complications, particularly with prolonged oxygen delivery exceeding 4 hours or flow rates above 2 L/min. This can lead to dry cough, increased secretions, and impaired mucociliary clearance. Humidification of inspired oxygen is essential to mitigate these effects, especially in cats and brachycephalic dogs.

• Monitoring protocols are critical for early detection of complications, focusing on serial pulse oximetry (SpO₂), arterial blood gas analysis (PaO₂, PaCO₂), respiratory rate and effort scoring, and thoracic radiographs. Titrating oxygen to achieve target SpO₂ (94-98%) rather than using fixed high flow rates is paramount to avoid hyperoxia and its associated risks.

• Gastric distension can occur due to aerophagia when oxygen flow rates exceed minute ventilation or when delivery devices create excessive dead space. Early detection involves serial abdominal palpation and auscultation, with corrective actions including reassessing flow rate and device position.

Oxygen therapy is a foundational intervention in canine and feline emergency and critical care. It is administered to treat hypoxemia from respiratory disease, cardiovascular compromise, and anesthetic complications. While the benefits of supplemental oxygen are well established, the therapy itself carries a spectrum of complications that range from mild mucosal irritation to life-threatening pulmonary injury. This article reviews the major complications of oxygen therapy in dogs and cats, including oxygen toxicity, absorption atelectasis, oxygen-induced hypoventilation, and the practical challenges of monitoring patients on supplemental oxygen. It is written for practicing veterinarians who need a diagnostic framework for recognizing and managing these adverse effects in real time.

The clinical question this article answers is direct: when a patient deteriorates on oxygen therapy, is the oxygen helping or harming? Distinguishing disease progression from therapy-related injury requires an understanding of the underlying physiology and a disciplined approach to monitoring. The article assumes familiarity with oxygen delivery devices and flow rate calculations, which are covered in companion references. Instead, it focuses on the pathophysiological mechanisms, recognition strategies, and clinical decision points that define safe oxygen administration.

At a Glance

Physiology of Oxygen Handling and the Basis of Harm

Oxygen is carried in blood in two forms: dissolved in plasma and bound to hemoglobin. The dissolved fraction, governed by Henry's law, is directly proportional to the partial pressure of oxygen (PaO₂). The bound fraction follows the oxyhemoglobin dissociation curve, which is sigmoidal and influenced by temperature, pH, and 2,3-diphosphoglycerate concentration. In healthy dogs and cats breathing room air, PaO₂ ranges from 90 to 100 mm Hg at sea level, and hemoglobin is approximately 97% saturated. Supplemental oxygen increases both the dissolved fraction and the saturation of hemoglobin, but the relationship is not linear. Once hemoglobin is fully saturated, further increases in FiO₂ only raise the dissolved fraction, which contributes minimally to total oxygen content.

The same oxidative metabolism that sustains aerobic life generates reactive oxygen species (ROS) as byproducts. Under normal conditions, endogenous antioxidant systems, including superoxide dismutase, catalase, and glutathione peroxidase, neutralize these species. When ROS production overwhelms these defenses, oxidative stress damages cellular lipids, proteins, and DNA. This balance between ROS formation and elimination is described in the context of diabetic complications, where hyperglycemia induces free radical production while impairing antioxidant capacity. The same principle applies to pulmonary tissue exposed to supraphysiologic oxygen concentrations. The lung is uniquely vulnerable because it receives the highest oxygen tension of any organ and has a large surface area for ROS generation.

Oxygen Toxicity

Oxygen toxicity results from the direct cytotoxic effects of ROS on pulmonary tissue. The tracheobronchial tree and alveolar epithelium are the primary targets. High inspired oxygen concentrations increase the production of superoxide and hydroxyl radicals within mitochondria and cytoplasmic compartments. These species attack polyunsaturated fatty acids in cell membranes, initiating lipid peroxidation and disrupting the integrity of the alveolar-capillary barrier. The resulting injury manifests as tracheobronchitis, alveolar edema, and ultimately fibrosis if exposure is prolonged.

The threshold for clinically significant oxygen toxicity in dogs and cats is not precisely defined. Experimental data in other species suggest that FiO₂ above 0.6 for more than 24 to 48 hours carries meaningful risk, while FiO₂ of 1.0 can cause injury within 12 to 24 hours. However, these thresholds are extrapolated from laboratory models and may not translate directly to clinical patients with concurrent disease. The RECOVER Initiative guidelines for veterinary CPR acknowledge that oxygen administration during and after resuscitation is essential, but they do not specify a maximum safe duration or concentration. This reflects a genuine gap in the veterinary evidence base. In practice, the clinician must weigh the immediate need for oxygenation against the cumulative risk of pulmonary injury.

Clinical signs of oxygen toxicity are nonspecific and overlap with the underlying respiratory disease. Early findings include coughing, tachypnea, and a progressive decline in arterial oxygenation despite stable or increasing FiO₂. Thoracic radiographs may show interstitial to alveolar patterns that are indistinguishable from pneumonia or pulmonary edema. The key diagnostic clue is temporal association: deterioration that occurs after a period of stable or improving oxygenation on high FiO₂ should raise suspicion for oxygen toxicity. The management is reduction of FiO₂ to the lowest level that maintains acceptable oxygenation, typically a PaO₂ of 80 to 110 mm Hg or SpO₂ of 94% to 98%.

Recognition of Complications: A Structured Approach

Complications of oxygen therapy often develop insidiously and may be masked by the underlying disease process. A structured monitoring protocol is essential because clinical signs of oxygen toxicity, absorption atelectasis, and hypoventilation overlap with signs of the primary respiratory condition. The following table provides a framework for recognizing each complication, its preventive measures, and the monitoring parameters that detect it early.

Oxygen Toxicity in Clinical Practice

The pathogenesis of oxygen toxicity centers on excessive reactive oxygen species generation when cellular antioxidant defenses are overwhelmed. Hyperoxia increases mitochondrial superoxide production, and the resulting oxidative stress damages pulmonary endothelial and epithelial cells. The lung is the primary target because it is exposed to the highest oxygen tension in the body. The relationship between oxidative stress and tissue injury is well established in other disease states, including diabetic complications and chronic kidney disease, where reactive oxygen species overwhelm endogenous antioxidant systems such as glutathione and superoxide dismutase Matough et al., institutional publication on oxidative stress and diabetic complications. The same biochemical principle applies to hyperoxic lung injury, although the time course in veterinary patients is compressed relative to chronic disease models.

Clinical oxygen toxicity in dogs and cats is predominantly a concern in patients receiving FiO2 above 0.60 for more than 24 to 48 hours. Early changes include tracheobronchial irritation, cough, and substernal discomfort. Prolonged exposure produces alveolar capillary membrane damage, interstitial edema, and eventually hyaline membrane formation. The radiographic appearance mimics acute respiratory distress syndrome, which complicates diagnosis in patients already being treated for pulmonary disease.

The decision to reduce FiO2 should be guided by the patient's oxygenation target instead of a fixed weaning schedule. For most dogs and cats, an SpO2 of 92% to 97% or a PaO2 of 80 to 100 mmHg is adequate. If the patient maintains these targets on a lower FiO2, reduction should proceed. In ventilated patients, FiO2 should be weaned toward 0.40 or less while PEEP is adjusted to maintain alveolar recruitment. The RECOVER guidelines emphasize goal-directed titration of oxygen and ventilation parameters in the post-arrest period, where both hypoxemia and hyperoxia are associated with worse outcomes RECOVER Initiative Veterinary CPR Guidelines.

Absorption Atelectasis

Absorption atelectasis occurs when high alveolar oxygen tensions cause gas to be absorbed from alveoli faster than it can be replaced when airway obstruction develops. Oxygen is highly soluble in blood, so alveoli supplied by partially obstructed airways collapse more readily when filled with oxygen than when filled with room air. This complication is most relevant in patients with bronchial secretions, mucus plugs, or bronchoconstriction, where regional ventilation is already compromised.

The clinical consequence is a paradoxical decline in oxygenation despite continued high FiO2. The patient may show increasing respiratory effort, and blood gas analysis reveals a falling PaO2/FiO2 ratio. In spontaneously breathing patients, the condition is often reversible with repositioning, chest physiotherapy, and reduction of FiO2 to the minimum required. In mechanically ventilated patients, PEEP is the primary countermeasure because it maintains alveolar patency during expiration.

Species differences matter. Cats have smaller airways and are prone to bronchoconstriction with airway irritation, making them more susceptible to absorption atelectasis when high oxygen flows are delivered without humidification. Brachycephalic dogs with upper airway obstruction and concurrent lower airway disease are also at increased risk. In these patients, the threshold for reducing FiO2 should be lower, and the clinician should prioritize addressing the underlying airway obstruction over maintaining high oxygen concentrations.

Oxygen-Induced Hypoventilation

Oxygen-induced hypoventilation is a recognized phenomenon in human patients with chronic hypercapnia, where oxygen administration blunts hypoxic respiratory drive and increases ventilation-perfusion mismatch through release of hypoxic pulmonary vasoconstriction. The relevance in veterinary patients is less clearly defined, but the mechanism warrants consideration in specific populations.

Dogs and cats with chronic respiratory disease and compensated hypercapnia, such as severe brachycephalic airway syndrome, chronic bronchitis, or laryngeal paralysis, may rely on hypoxic drive to maintain ventilation. Administering high FiO2 can reduce respiratory drive and worsen hypercapnia. The clinical picture is one of progressive lethargy, reduced respiratory effort, and rising PaCO2 on blood gas analysis.

The correct approach is not to withhold oxygen from hypoxemic patients but to titrate carefully. Target the lowest FiO2 that achieves acceptable oxygenation, and monitor PaCO2 serially in patients at risk. In patients with suspected oxygen-induced hypoventilation, the response to reduced FiO2 should be assessed within 30 to 60 minutes. If hypercapnia persists despite FiO2 reduction, the patient may require ventilatory support instead of continued spontaneous breathing.

Monitoring Protocols and Documentation

Monitoring should be tailored to the delivery method and the patient's underlying condition. Continuous pulse oximetry is the minimum standard for any patient receiving supplemental oxygen. SpO2 values above 97% suggest that FiO2 may be reduced, while values below 92% indicate inadequate oxygenation or a need to reassess the delivery system. Blood gas analysis provides the definitive assessment of oxygenation and ventilation and should be performed at baseline, after any significant FiO2 change, and whenever clinical deterioration occurs.

The frequency of monitoring depends on patient stability. Critically ill patients on high FiO2 should have SpO2 and respiratory effort assessed every 1 to 2 hours, with blood gas analysis every 4 to 6 hours or after any change in oxygen settings. Stable patients on low FiO2 can be monitored every 4 hours with SpO2 and clinical assessment. Thoracic radiographs should be repeated if oxygenation worsens or if the clinical picture changes, because the differential diagnosis includes progression of the primary disease, ventilator-associated pneumonia, and oxygen-induced lung injury.

Documentation should include the delivery method, flow rate or FiO2, SpO2 or blood gas values, respiratory rate and effort, and any complications observed. This record supports clinical decision-making over time and provides a basis for weaning decisions. The AAHA and AAFP fluid therapy guidelines emphasize the importance of structured monitoring and documentation for all therapeutic interventions, and the same principle applies to oxygen therapy AAHA and AAFP fluid therapy guidelines for dogs and cats.

Equipment choices influence complication risk. Nasal prongs and cannulas should be sized to the patient to avoid mucosal contact. Oxygen cages allow precise FiO2 control but require frequent opening for patient access, which causes FiO2 fluctuations and may necessitate higher flow rates. Humidification should be used for flow rates above 2 L/min or when delivery exceeds 12 hours. In ventilated patients, heated humidification is standard and reduces the risk of airway drying and secretion impaction.

The correct monitoring intensity also depends on the clinical setting. A referral intensive care unit with continuous capnography and frequent blood gas analysis can detect complications earlier than a general practice with intermittent monitoring. Clinicians should adjust their monitoring frequency to the available resources and the patient's risk profile, recognizing that delayed detection of oxygen toxicity or absorption atelectasis worsens outcomes.

Recognized Complications and Early Detection

Beyond the core triad of oxygen toxicity, absorption atelectasis, and hypoventilation, several additional failure modes merit attention in the oxygen-dependent veterinary patient.

Nasal mucosal injury develops from prolonged contact with dry, cold, or high-velocity gas streams. Early signs include serous discharge, sneezing, and visible mucosal erythema. Detection relies on daily visual inspection of the nares and external nares skin. Humidification and periodic repositioning of nasal prongs reduce incidence.

Gastric distension occurs when flow rates exceed the patient's minute ventilation or when the delivery device creates excessive dead space. Early detection requires serial abdominal palpation and auscultation. A patient that develops progressive abdominal distension, restlessness, or vomiting while on oxygen should have flow rate and device position reassessed immediately.

Ocular drying and corneal ulceration develop in recumbent patients, particularly those with reduced tear production or incomplete blink reflexes. Daily fluorescein staining is indicated in any patient receiving oxygen for more than 24 hours with ocular exposure.

Thermal injury from heated humidifiers or oxygen concentrators is rare but reported. Detection relies on checking device surface temperatures and inspecting skin contact points.

Fire risk increases with oxygen-enriched environments. Open flames, electrical sparks, and static discharge become hazardous. Detection is preventive: routine checks of equipment integrity, avoidance of petroleum-based lubricants, and clear signage in oxygen administration areas.

Common Errors and Corrective Actions

Less experienced clinicians frequently make several predictable errors.

Error: Equating oxygen saturation with ventilation. A patient can maintain normal SpO2 while developing progressive hypercapnia. Corrective action: measure PaCO2 or EtCO2 in any patient with deteriorating mentation, rising respiratory rate, or declining tidal volume despite stable oxygenation.

Error: Failing to reduce FiO2 after stabilization. Many patients remain on unnecessarily high oxygen fractions for prolonged periods. Corrective action: titrate FiO2 to the lowest fraction that maintains target SpO2, typically 94 to 98 percent in dogs and cats, and document the weaning plan.

Error: Ignoring the oxygen delivery device as a source of respiratory distress. A patient that becomes agitated or dyspnoeic after oxygen administration may be reacting to the device itself, not the underlying disease. Corrective action: temporarily remove the device while providing manual oxygen support to differentiate device intolerance from clinical deterioration.

Error: Delaying intubation and mechanical ventilation. Some patients exhaust compensatory effort while on oxygen therapy. Corrective action: establish clear criteria for intubation based on blood gas values, work of breathing, and mentation before the patient becomes moribund.

Error: Overlooking the contribution of pain or anxiety to oxygen consumption. A distressed patient has higher metabolic demand and oxygen consumption. Corrective action: address analgesia and sedation as part of the oxygen therapy plan, not as an afterthought.

Troubleshooting Table

Evidence Limitations and Divergent Expert Opinion

The evidence base for oxygen therapy complications in veterinary patients is largely extrapolated from human medicine and experimental animal models. Direct comparative studies in dogs and cats are limited. The RECOVER Initiative veterinary CPR guidelines provide structured recommendations for post-arrest oxygen management, but they do not resolve questions about optimal FiO2 targets during prolonged oxygen therapy.

Expert opinion diverges on several points. The threshold FiO2 above which pulmonary oxygen toxicity becomes clinically significant in dogs and cats remains unsettled. Some authorities recommend avoiding FiO2 above 60 percent for more than 24 hours, while others accept higher fractions when hypoxemia is life-threatening. Similarly, the role of antioxidants in mitigating oxygen toxicity is supported by mechanistic work in other disease states, such as the oxidative stress pathways described in diabetic complications, but no veterinary clinical trials confirm benefit in oxygen-treated patients.

The interaction between oxygen therapy and pre-existing oxidative stress is another area of uncertainty. Patients with chronic inflammatory disease may have altered antioxidant capacity, as described in chronic kidney disease and oxidative stress, but whether this increases susceptibility to oxygen toxicity in clinical practice is not established.

Referral, Consultation, and Reporting

Referral to a specialist is warranted when a patient requires FiO2 above 60 percent for more than 24 hours, develops progressive hypercapnia despite oxygen therapy, or fails to wean from oxygen within an expected timeframe. Board-certified emergency and critical care specialists should be consulted before initiating mechanical ventilation in most general practice settings.

Laboratory involvement is indicated for serial arterial blood gas analysis, particularly when PaO2 and PaCO2 trends guide clinical decisions. Point-of-care analyzers are acceptable for trend monitoring, but results should be interpreted with awareness of their precision limits.

Regulatory reporting obligations vary by jurisdiction. The WOAH terrestrial animal health standards address oxygen therapy only indirectly through general anesthesia and surgical standards. Veterinary professionals should consult their local regulatory body for specific reporting requirements related to anesthetic complications or medical errors. The AVMA practice resources provide general guidance on professional conduct and adverse event documentation, though they do not mandate specific reporting thresholds for oxygen therapy complications.

Documentation of oxygen therapy, including FiO2, delivery method, monitoring parameters, and complications, should follow the same standards as any medical intervention. The AAHA/AAFP fluid therapy guidelines illustrate the expected rigour for monitoring and complication documentation in small animal practice, and oxygen therapy warrants comparable attention.

Frequently Asked Questions

How Do I Manage Oxygen Therapy When Only a Single Oxygen Source Is Available?

When one oxygen source must serve multiple patients, prioritize those with the highest oxygen dependency and the greatest risk of rapid decompensation. Patients with refractory hypoxemia, traumatic brain injury, or upper airway obstruction take precedence. For stable patients, consider intermittent therapy with close monitoring for desaturation during off periods. Document the rationing decision and reassess every 30 to 60 minutes. If a patient deteriorates, reallocate the source and escalate monitoring frequency. The RECOVER Initiative veterinary CPR guidelines emphasize that oxygen delivery is a resuscitation priority, so any interruption should trigger immediate re-evaluation of the patient's respiratory status and perfusion parameters.

What Monitoring Is Feasible in a General Practice Setting Without Advanced Equipment?

Pulse oximetry, mucous membrane color, respiratory rate and effort, and serial arterial blood gas sampling when available form the core monitoring set. Pulse oximetry has recognized limitations in hypothermic, vasoconstricted, or anemic patients, so interpret trends instead of absolute values. Capnography, where available, provides useful ventilation monitoring in intubated patients. Serial thoracic radiographs are indicated when absorption atelectasis or pneumonia is suspected. The AAHA/AAFP fluid therapy guidelines reinforce that structured monitoring protocols with documented parameters improve complication detection, even when equipment is limited. Record every parameter at each check, including the fraction of inspired oxygen and the delivery method, to allow retrospective analysis of complication onset.

How Should I Explain Oxygen Therapy Complications to an Owner?

Use concrete language that distinguishes expected effects from true complications. Explain that oxygen is a drug with dose-related effects, and that the veterinary team monitors for those effects continuously. Describe the specific complication you are managing, for example absorption atelectasis as a gradual collapse of small air sacs, or oxygen-induced hypoventilation as a reduction in breathing drive. Frame the discussion around the risk-benefit balance: the oxygen is supporting vital organ function while the underlying disease is treated. The MSD Veterinary Manual provides accessible descriptions of respiratory physiology that can help structure owner explanations. Offer a realistic timeline for reassessment and be explicit about the criteria that would prompt a change in therapy.

Does Oxygen Toxicity Occur in Cats Differently Than in Dogs?

Cats appear more susceptible to pulmonary oxygen toxicity than dogs, although direct comparative studies are limited. Feline patients exposed to high inspired oxygen fractions for prolonged periods may develop pulmonary changes earlier, including alveolar damage and interstitial edema. Clinical signs are non-specific and include tachypnoea, coughing, and progressive hypoxemia despite continued oxygen delivery. Because cats also develop hypoventilation more readily with sedatives and underlying pulmonary disease, their oxygen requirements should be titrated to the lowest fraction that maintains acceptable saturation. The RECOVER Initiative veterinary CPR guidelines note that post-arrest oxygen administration should be tapered as soon as spontaneous circulation is restored, a principle that applies particularly to feline patients.

What Should I Record in the Medical Record Regarding Oxygen Therapy?

Record the indication for oxygen therapy, the delivery method, the inspired oxygen fraction or flow rate, and the time of initiation. Document every adjustment, the patient's response, and any complication observed, including the time of onset and the corrective action taken. Serial recordings of respiratory rate, effort, pulse oximetry, and arterial blood gas values where available allow pattern recognition. Note any equipment malfunction or supply interruption. The AAHA/AAFP fluid therapy guidelines model this documentation standard for fluid therapy, and the same rigour applies to oxygen. Accurate records support clinical decision-making, facilitate continuity between shifts, and provide a defensible basis for treatment choices if outcomes are questioned.

When Should I Stop Oxygen Therapy Because of Complications?

Stop or reduce oxygen when the patient maintains acceptable oxygenation on a declining inspired fraction, or when a complication threatens to outweigh the benefit. Oxygen-induced hypoventilation that progresses to hypercapnia with altered mentation warrants reduction of the inspired fraction and consideration of ventilatory support. Absorption atelectasis that worsens despite repositioning and physiotherapy should prompt a trial of lower oxygen with close monitoring. There is no universal threshold, but a patient who deteriorates clinically while receiving high oxygen fractions requires immediate reassessment of the underlying diagnosis. The MSD Veterinary Manual advises that oxygen therapy should be titrated to effect and discontinued as soon as the patient can maintain adequate oxygenation on room air, with weaning guided by serial blood gas or saturation measurements.

Related Clinical & Scientific Guides

• Toxicology in Emergency Practice: Common Poisons and Diagnostic Approach
• Veterinary Cardiopulmonary Resuscitation: Post-Cardiac Arrest Care
• Fluid Therapy Guidelines for Dogs and Cats: A Practical Update

References and Further Reading

• The role of oxidative stress and antioxidants in diabetic complications.. 2012.
• Oxidative stress in atrial fibrillation: an emerging role of NADPH oxidase.. 2013.
• Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease.. 2013.
• Oxidative stress and diabetic retinopathy.. 2007.
• The missing link: a single unifying mechanism for diabetic complications.. 2000.
• An update on the evidence for pathogenic mechanisms that may link periodontitis and diabetes.. 2018.
• RECOVER Initiative Veterinary CPR Guidelines. Veterinary Emergency and Critical Care Society.
• AAHA/AAFP Fluid Therapy Guidelines for Dogs and Cats. AAHA.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.

Related Articles

• Hyperbaric Oxygen Therapy in Veterinary Patients: Evidence and Applications
• Oxygen Therapy Delivery Methods in Veterinary Critical Care
• Veterinary Oxygen Therapy: Flow Rates and Delivery Devices
• Veterinary Fluid Therapy: Crystalloids vs Colloids
• Failure Modes in Mechanical Ventilation of Veterinary Patients

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.